Concluding Session and Closing Ceremony: The Tehran Communique
Authors: not saved
Abstract:
This article doesn't have abstract
similar resources
Commentary. Concluding remarks on Session III
A total of 61 eligible patients with metastatic cancer have been treated in a series of Phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were colorectal (23), renal (21), and non small cell lung (17). No patient had received prior chemotherapy. The drug was given intravenously as a 20 min infusion at the dose of 120 mg-2 on days 1 to 5 every 3 weeks. Treatment w...
full textCommentary. Concluding remarks on Session II
The assessment of human cancer risk from exposure to chemicals in aquatic environments includes understanding such factors as chemical inputs, bioaccumulation, metabolism, foodchain transfer and biological effects. The estimation of the risk to humans is dependent on being able to evaluate the net effect of these complementary parameters on human populations, recognizing that humans are ultimat...
full textCommentary. Concluding remarks on Session I
The papers presented during the first session have provided a useful introduction and a review of several important points that have been established during the past decade. Many carefully studied near shore marine environments and freshwater lakes are polluted with chemicals as indicated primarily by measurements of certain organics and metals in sediments. Fish and shellfish, including bivalv...
full textPanel Session - Who Is Closing the embedded software design gap?
As pointed out in the ITRS roadmap, the level of embedded software complexity is greater than the pure HW complexity of SoCs when comparing, for example, lines of HDL and C code. Even worse, SW complexity grows faster than HW complexity (Moore's Law) and SW productivity increases more slowly than HW productivity. A new design gap-the gap of embedded software – as appeared. EDA has now identifie...
full textMy Resources
Journal title
volume 3 issue شماره 35 و 36
pages 129- 13
publication date 2011-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023